• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Comparative Study on Willingness to Pay for Breast Cancer and Osteoporosis Screening in Kerman, Southeastern Iran.伊朗东南部克尔曼地区乳腺癌和骨质疏松症筛查支付意愿的比较研究
Iran J Public Health. 2017 May;46(5):693-698.
2
Women's Preference for Cervical Cancer Screening Methods in Iran: A Contingent Valuation Survey.伊朗女性对宫颈癌筛查方法的偏好:一项条件价值评估调查。
Med J Islam Repub Iran. 2022 Jun 30;36:72. doi: 10.47176/mjiri.36.72. eCollection 2022.
3
Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer.伊朗女性对基因相关疾病筛查的主观评估:以乳腺癌为例。
BMC Public Health. 2023 Apr 11;23(1):667. doi: 10.1186/s12889-023-15568-0.
4
Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study.韩国转移性乳腺癌患者癌症治疗支付意愿的评估:一项多中心横断面研究。
Asia Pac J Clin Oncol. 2012 Sep;8(3):282-91. doi: 10.1111/j.1743-7563.2012.01546.x. Epub 2012 May 21.
5
Willingness to pay for diagnostic technologies: a review of the contingent valuation literature.支付意愿研究:诊断技术价值评估文献综述
Value Health. 2013 Jul-Aug;16(5):797-805. doi: 10.1016/j.jval.2013.04.005. Epub 2013 Jun 14.
6
Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.应用离散事件模拟模型评价中国老年女性骨质疏松治疗的成本效益阈值。
Osteoporos Int. 2017 Feb;28(2):529-538. doi: 10.1007/s00198-016-3751-z. Epub 2016 Aug 31.
7
Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.效用值和支付意愿是否能恰当地反映髋膝关节骨关节炎的健康结果?与WOMAC指数的比较分析。
J Rheumatol. 2003 Nov;30(11):2452-9.
8
Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.使用条件价值评估法评估类风湿关节炎的假设性治愈方法:患者视角
J Rheumatol. 2005 Mar;32(3):443-53.
9
Women's willingness to pay out-of-pocket for drug treatment for osteoporosis before and after the enactment of regulations providing public funding: evidence from a natural experiment in Israel.在提供公共资金的法规颁布前后,女性自掏腰包支付骨质疏松症药物治疗费用的意愿:来自以色列一项自然实验的证据。
Osteoporos Int. 2002 Mar;13(3):228-34. doi: 10.1007/s001980200019.
10
Willingness to Pay in Caregivers of Patients Affected by Schizophrenia.精神分裂症患者照料者的支付意愿
J Ment Health Policy Econ. 2017 Mar 1;20(1):3-10.

引用本文的文献

1
Willingness and ability to pay for breast cancer treatment among patients from Addis Ababa, Ethiopia: A cross-sectional study.埃塞俄比亚亚的斯亚贝巴的乳腺癌患者对治疗的支付意愿和能力:一项横断面研究。
PLoS One. 2024 Mar 28;19(3):e0300631. doi: 10.1371/journal.pone.0300631. eCollection 2024.
2
Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel.对基于mRNA的抗癌治疗的支付意愿:以色列一项条件价值评估研究的结果
Isr J Health Policy Res. 2024 Feb 19;13(1):9. doi: 10.1186/s13584-024-00594-z.
3
Patient Preferences in Diagnostic Imaging: A Scoping Review.诊断成像中的患者偏好:一项范围综述
Patient. 2023 Nov;16(6):579-591. doi: 10.1007/s40271-023-00646-7. Epub 2023 Sep 4.
4
Knowledge, Practice, Preferences and Willingness-to-Pay for Mammographic Screening Tests among Iranian Women: A Contingent Valuation Method.伊朗女性对乳房 X 光筛查测试的知识、实践、偏好和支付意愿:一种条件价值评估方法。
Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1207-1213. doi: 10.31557/APJCP.2022.23.4.1207.

本文引用的文献

1
Discrete choice experiment to estimate breast cancer patients' preferences and willingness to pay for prophylactic granulocyte colony-stimulating factors.离散选择实验估计乳腺癌患者对预防性粒细胞集落刺激因子的偏好和支付意愿。
Value Health. 2014 Jun;17(4):380-9. doi: 10.1016/j.jval.2014.01.002. Epub 2014 Mar 27.
2
The value of a QALY: individual willingness to pay for health gains under risk.QALY 的价值:风险下个人对健康收益的支付意愿。
Pharmacoeconomics. 2014 Jan;32(1):75-86. doi: 10.1007/s40273-013-0110-1.
3
Men's preferences for prostate cancer screening: a discrete choice experiment.男性对前列腺癌筛查的偏好:一项离散选择实验。
Br J Cancer. 2013 Feb 19;108(3):533-41. doi: 10.1038/bjc.2013.5. Epub 2013 Jan 29.
4
Eliciting patients' preferences for outpatient treatment of febrile neutropenia: a discrete choice experiment. eliciting patients' preferences for outpatient treatment of febrile neutropenia: a discrete choice experiment.
Support Care Cancer. 2013 Jan;21(1):245-51. doi: 10.1007/s00520-012-1517-5. Epub 2012 Jun 9.
5
Measuring Preferences for Colorectal Cancer Screening: What are the Implications for Moving Forward?测量对结直肠癌筛查的偏好:这对前进有何影响?
Patient. 2010 Jun 1;3(2):79-89. doi: 10.2165/11532250-000000000-00000.
6
American Cancer Society guidelines for the early detection of cancer, 2006.美国癌症协会2006年癌症早期检测指南。
CA Cancer J Clin. 2006 Jan-Feb;56(1):11-25; quiz 49-50. doi: 10.3322/canjclin.56.1.11.
7
Perceived barriers and benefits to cervical cancer screening in Latin America.拉丁美洲宫颈癌筛查的感知障碍和益处
Prev Med. 2004 Jul;39(1):91-8. doi: 10.1016/j.ypmed.2004.03.040.
8
A comparison of two methods for eliciting contingent valuations of colorectal cancer screening.两种用于引出结直肠癌筛查条件价值评估的方法比较。
J Health Econ. 2003 Jul;22(4):555-74. doi: 10.1016/S0167-6296(03)00006-7.
9
Willingness-to-pay as a measure of benefits. Relevant questions in the context of public decisionmaking about health care programs.支付意愿作为衡量收益的指标。在关于医疗保健项目的公共决策背景下的相关问题。
Med Care. 1991 Dec;29(12):1246-52.

伊朗东南部克尔曼地区乳腺癌和骨质疏松症筛查支付意愿的比较研究

A Comparative Study on Willingness to Pay for Breast Cancer and Osteoporosis Screening in Kerman, Southeastern Iran.

作者信息

Sabermahani Asma, Mohammad Taghizade Sedighe, Goodarzi Reza

机构信息

Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

Iran Health Insurance Organization, Kerman, Iran.

出版信息

Iran J Public Health. 2017 May;46(5):693-698.

PMID:28560201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5442283/
Abstract

BACKGROUND

One of the economic evaluation techniques involves calculation of willingness to pay (WTP) for a service to find out the value of that service from the clients' perspective. This study estimated WTP for both breast cancer and osteoporosis screening and comparatively examined the contributing factors. In fact, the comparisons served to provide an exact analysis of individual attitudes and behaviors in relation to screening programs for cancers and other diseases.

METHODS

This study was first designed in six scenarios several questionnaires concerning individual breast cancer and osteoporosis screening cases, and determined the WTP median in each scenario between people in Kerman Province of Iran in 2016. Then, the demand function for breast cancer and osteoporosis screening was formulated. Moreover, the factors contributing to WTP were examined through various scenarios in Stata and econometric techniques.

RESULTS

The median and mean values of WTP in all the above scenarios were greater for breast cancer screening than for osteoporosis screening. Theoretically, the price assumed a minus sign whereas risk assumed a plus sign within the demand function formulated for both screening programs. Regarding the evaluated factors, age in breast cancer screening and risk of disease in osteoporosis screening were the major factors contributing to WTP.

CONCLUSION

Breast cancer screening was more valuable than osteoporosis screening program from the perspective of the subjects. The programs can be successfully designed by concentrating on patients' age groups in breast cancer screening and high-risk patients in osteoporosis screening.

摘要

背景

经济评估技术之一涉及计算对一项服务的支付意愿(WTP),以便从客户角度找出该服务的价值。本研究估计了乳腺癌和骨质疏松症筛查的支付意愿,并对影响因素进行了比较研究。事实上,这些比较有助于对与癌症及其他疾病筛查项目相关的个人态度和行为进行精确分析。

方法

本研究首先设计了六种情景,涉及若干关于个人乳腺癌和骨质疏松症筛查情况的问卷,并确定了2016年伊朗克尔曼省居民在每种情景下的支付意愿中位数。然后,构建了乳腺癌和骨质疏松症筛查的需求函数。此外,通过Stata中的各种情景和计量经济学技术,研究了影响支付意愿的因素。

结果

在上述所有情景中,乳腺癌筛查的支付意愿中位数和平均值均高于骨质疏松症筛查。理论上,在为两个筛查项目构建的需求函数中,价格的系数为负,而风险的系数为正。在评估的因素中,乳腺癌筛查中的年龄和骨质疏松症筛查中的疾病风险是影响支付意愿的主要因素。

结论

从受试者的角度来看,乳腺癌筛查比骨质疏松症筛查项目更有价值。通过关注乳腺癌筛查中的患者年龄组和骨质疏松症筛查中的高危患者,可以成功设计这些筛查项目。